Capricor Therapeutics Prices Public Offering Of 4.412M Shares Of Common Stock At $17.00 Per Share

The gross proceeds from the offering are expected to be approximately $75 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Capricor and assuming no exercise of the underwriters' option.